NR1H4 and metabolic dysfunction-associated steatotic liver disease: It is a synthetic variant of the natural bile acid chenodeoxycholic acid, which acts as a ligand for FXR and may play a therapeutic role in NAFLD by activating FXR to reduce hepatic lipogenesis and degeneration.25